Market Tracker

09/04 3:35am ET

Galectin Therapeutics Inc (NASDAQ:GALT)

2.06
Delayed Data
As of Sep 03
 -0.04 / -1.90%
Today’s Change
1.68
Today|||52-Week Range
6.60
-40.63%
Year-to-Date
No recent news for Galectin Therapeutics Inc.

Today’s Trading

Previous close2.10
Today’s open2.10
Day’s range2.03 - 2.18
Volume61,353
Average volume (3 months)201,925
Market cap$47.9M
Dividend yield--
Data as of 09/03/2015

Growth & Valuation

Earnings growth (last year)+40.00%
Earnings growth (this year)-8.97%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.27

Competitors

----
APHBAmpliPhi Biosciences...-0.21-3.05%
TROVUTrovagene Inc0.000.00%
INISInternational Isotop...-0.01-10.11%
Data as of 2:35pm ET, 09/03/2015

Financials

Next reporting dateNovember 12, 2015
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$0.00
Annual profit (last year)-$16.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Director &
Chief Medical Officer
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts